Trending
Adding a “Cognition Bolt-on” to EQ-5D-5L: Insights from New Research and What’s Next

Adding a “Cognition Bolt-on” to EQ-5D-5L: Insights from New Research and What’s Next

Read more
Rare Disease day 2025

Advancing Rare Disease Care: Challenges and Key Issues

Read more
#image_title
EQ-5D and beyond: OHE’s contributions to EuroQol research and meetings

EQ-5D and beyond: OHE’s contributions to EuroQol research and meetings

Read more

What role can pharmaceuticals play in saving the planet?

What can we learn from the UK in navigating the digital health landscape?

We provide independent and pioneering resources, research and analyses

Our work in health economics, health policy and health statistics informs decision-making about health care and pharmaceutical issues at a global level.

£ 0 m

is the total preventable burden of cervical cancer in the UK

0 %

is the likelihood of developing dementia, becoming an informal carer, or both in a lifetime

0 %

of the NHS’s total carbon footprint accounts for the manufacture, supply, and use of pharmaceuticals

0 %

of total NHS funding was allocated to preventative care between 2013 and 2019.

0

clinical trials supported the first digital therapeutic recommended by NICE

OHE research themes & areas of expertise

Health Technology Assessment (HTA)

Drug Development/R&D

The Importance of Diversity of Supply in Rare Diseases Markets

The Importance of Diversity of Supply in Rare Diseases Markets

Read more
© VK Studio at stock.adobe.com
The Spotlight on Haemophilia

A Spotlight on Haemophilia Therapies 

Read more
© Ambartsumian at adobe.stock.com

Health Care Systems

Vaccines

Digital Health

Navigating the Landscape of Digital Health - United Kingdom

Navigating the Landscape of Digital Health – United Kingdom

Read more

Prevention